Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,474
A Crowd Sourcing Platform for Patients With Cancer
for
Cancer
Location: Seattle WA
Sponsor: All4Cure
Sex: All
Age: 18+
Code: NCT03530826
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
for
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma,
Location: Tacoma WA, Spokane WA, Fullerton CA, Milwaukee WI,
Sponsor: Panbela Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05254171
Phase 2, Phase 3, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Post Falls ID, Coeur d'Alene ID, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
for
Spinal Muscular Atrophy (SMA)
Location: Tacoma WA, Seattle WA, Portland OR, Sacramento CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0+
Code: NCT04174157
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
for
Colitis, Ulcerative
Location: Tacoma WA, Seattle WA, Sacramento CA, Los Angeles CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 2 - 17
Code: NCT05076175
Phase 2, Phase 3, Recruiting
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Tacoma WA, Saint Joseph MO, Oklahoma City OK, Joplin MO,
Sponsor: National Cancer Institute LAO
Sex: All
Age: 0+
Code: NCT02474160
Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study